Cyxone (publ) enters into a strategically important research collaboration with an acknowledged research group at University of Glasgow, UK, with the objective of performing an exploratory phase 2 study with rabeximod in patients with rheumatoid arthritis (RA). The research group at School of Infection and Immunity, University of Glasgow is an internationally recognised centre of excellence conducting high quality basic, translational and clinical research in the disciplines of infection, immunology and inflammation. The collaboration will be performed together with members of the Glasgow Rheumatic and Musculoskeletal Disease Group which is a world leading centre in RA research and other immune-mediated inflammatory diseases.

The researchers at the School of Infection and Immunity led by Professor Iain McInnes, also constitute one of the four corner stones of the consortium Research into Inflammatory Arthritis Centre Versus Arthritis (RACE), that together with the universities in Birmingham, Newcastle and Oxford have joined forces to perform translational research to gain a better understanding of the causes behind RA and how to treat it.